MRPL Q3 FY26 Concall Transcript Released: Discusses Financials, Bio-ATF Plant, and Retail Expansion
MRPL's Q3 FY26 concall transcript reveals significant Y-o-Y performance jump with EBITDA at ₹2,824 crore. The company is investing ₹364 crore in a Bio-ATF plant and expanding retail outlets to 250 by FY26, aiming for 1,000 in five years. Annual CAPEX is around ₹1,500 crore. Debt stands at ₹9,290 crore.
The announcement provides detailed financial performance for the quarter, strategic initiatives like the Bio-ATF plant and retail expansion, and insights into crude sourcing and debt management, all of which are material information for investors and stakeholders.
The company reported strong financial performance with a significant jump in EBITDA and achieved its best-ever MBN. Positive outlook on future performance, expansion plans for Bio-ATF and retail outlets, and efforts to manage debt contribute to a positive sentiment.
Mangalore Refinery and Petrochemicals Limited (MRPL) has released the transcript of its conference call held on January 19, 2026, to discuss the un-audited financial results for the quarter and nine months ended December 31, 2025. The company reported a significant year-on-year and quarter-on-quarter jump in performance, with EBITDA at ₹2,824 crore compared to ₹1,064 crore in the previous year's Q3. MRPL achieved its best-ever MBN (a measure for energy efficiency) of 67 and maintained fuel and loss at 10.06%. Current debt stands at ₹9,290 crore with a debt-equity ratio of 0.63.
The company is establishing a Bio-ATF plant at a cost of ₹364 crore, which will help comply with CORSIA norms and enable the supply of blended ATF globally starting from 2027. MRPL is also expanding its retail outlets, having reached 200 outlets and aiming for 250 by the end of the fiscal year. The company expects to continue its operational performance and post healthy Q4 results.
During the call, management addressed concerns regarding crude sourcing changes, stating that Russian crude was always a marginal factor and its absence is offset by strong finished product cracks. They also discussed freight rates, noting they have come down from their peak. The company is exploring energy integration and aims to bring fuel and loss below 10% with a grid power project.
MRPL is also focusing on its retail business as a significant growth driver, with plans to expand to 500 outlets in three years and 1,000 in five years, supported by investments in depots and pipeline infrastructure. The company is also well-positioned for ATF marketing, expecting growth with its tie-up for CORSIA compliance.
Regarding capital expenditure, MRPL targets approximately ₹1,500 crore annually, covering revamping and new projects like the IBB pilot plant and grid infrastructure. The company's dividend policy will be considered by the board based on Q4 profitability and CAPEX requirements. The current debt stands at ₹9,290 crore, with NCDs locked until 2028.
What to do with a filing like this
Mangalore Refinery and Petrochemicals Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mangalore Refinery and Petrochemicals Limited. Read the original for the full detail.